Investing Profile
Kulika Weizman(358)
Your Intro Paths to Kulika Weizman
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Kulika Weizman's investing connections
10 Investors
Connected to Saar Gur (CRV), Brian Frank (FTW Ventures), Aaron Holiday (645 Ventures), and 7 other investors on Signal.
Networks Kulika is a member of
University of California, Berkeley Network
501 CONNECTIONS
University of Pennsylvania Network
330 CONNECTIONS
University of Pennsylvania - The Wharton School Network
239 CONNECTIONS
Siemens Network
65 CONNECTIONS
Penn Medicine Co-Investment Program Network
28 CONNECTIONS
Find Kulika Weizman on
cbCurrent Investing Position
Creative Ventures General Partner
Investment Range
$500K - $1M
Sweet Spot
$750K
Investments On Record
5
Current Fund Size
$50M
Kulika Weizman is on these Sector & Stage Rankings
Medical Devices (Seed)Robotics (Seed)EnergyTech (Seed)TransportationTech (Seed)ClimateTech/CleanTech (Seed)BioTech (Seed)Manufacturing (Seed)Diverse InvestorsFemale InvestorsInvestors who were foundersInvestors who invested in female foundersInvestors who invested in diverse foundersSan Francisco Bay AreaConstructionTech (Seed)Diagnostics (Seed)DeepTech (Seed)
Kulika Weizman's Investments On Record (4)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Rhaeos | Series AFeb 2023$11M SeedDec 2021$2M | $13M |
OncoPrecision | SeedAug 2022$3M | $11M |
VenoStent | Seed Jan 2021$3M  | $26M |
Mobio Interactive | SeedSep 2020$2M | $2M |
Kulika Weizman's Experience
Research Assistant Penn Medicine Co-Investment ProgramPresent
Independent Consultant American Society for Cell Biology (ASCB)Present
Graduate Student Researcher Energy & Biosciences InstitutePresent
Co-founder & CEO NAMUHPresent
Senior Associate Creative VenturesPresent
Principal Creative VenturesPresent
Investor Cytonus TherapeuticsPresent
Board Observer NxLitePresent
Board Observer SYNVIVIAPresent
Board Observer KOLIBRIPresent
Board Observer Tierra BiosciencesPresent
Board Observer VenoStent, Inc.Present
General Partner Creative VenturesPresent
Emerging Technologies Investor SiemensPresent
Graduate Student Researcher Energy Biosciences InstitutePresent
Research Assistant University of Pennsylvania - Computer Science & Engineering DepartmentPresent
Independent Consultant ASCB (American Society for Cell Biology)Present
Co-founder & CEO SugarlogixPresent
Research Scientist BIOTECPresent
Board Member VenoStent, Inc.Present
Board Observer RhaeosPresent
Board Observer OncoPrecisionPresent
Investor Mobio InteractivePresent
CEO & Co-founder Sugarlogix2016 - 2018
Kulika Weizman's Education
University of Pennsylvania B.S. Chemical & Biomolecular Engineering
University of Pennsylvania - The Wharton School B.S. Economics
University of California, Berkeley Ph.D. Microbiology
Investors who invest with Kulika Weizman
Scouts & Angels Affiliated With Kulika Weizman